P. Wijermans

Quality of life after successful treatment of early-stage Hodgkin's lymphoma: 10-year follow-up of the EORTC–GELA H8 randomised controlled trial

Natacha Heutte, Hans‐Henning Flechtner, Nicolas Mounier et al. · The Lancet Oncology · 2009 · 103 citations

Quality Of Life, Lymphoid Neoplasia, 10-Year Follow-up +6

Addition of bevacizumab to chemotherapy in acute myeloid leukemia at older age: a randomized phase 2 trial of the Dutch-Belgian Cooperative Trial Group for Hemato-Oncology (HOVON) and the Swiss Group for Clinical Cancer Research (SAKK)

Gert J. Ossenkoppele, Georg Stüssi, Johan Maertens et al. · Blood · 2012 · 73 citations · Full text

Clinical Experience with Fludarabine and its Immunosuppressive Effects in Pretreated Chronic Lymphocytic Leukemias and Low-Grade Lymphomas

Klaus Fenchel, Lothar Bergmann, P. Wijermans et al. · Leukemia & lymphoma/Leukemia and lymphoma · 1995 · 66 citations

MP versus MPT for previously untreated elderly patients with multiple myeloma: A meta-analysis of 1,682 individual patient data from six randomized clinical trials.

Anders Waage, Antonio Palumbo, Peter Fayers et al. · Journal of Clinical Oncology · 2010 · 19 citations

Elderly Patients, Cancer Management, Clinical Specialties +17

Costs of multiple myeloma and associated skeletal-related events in The Netherlands

Martijn Groot, Peter C. Huijgens, P. Wijermans et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 2004 · 18 citations

Total Cost, Surgery, Osteoporosis +17